Can Wegovy help with weight loss, and who is medically eligible in Europe?

Wegovy for weight loss explained: semaglutide 2.4 mg, GLP-1 receptor agonist therapy, BMI criteria, appetite regulation, and prescribing standards.

In this episode, we outline how Wegovy works and how doctors assess eligibility under EU medical guidance.

You’ll learn:

• What semaglutide is and how GLP-1 reduces appetite and calorie intake

• Approved BMI thresholds (≥30, or ≥27 with weight-related conditions such as hypertension or type 2 diabetes)

• Expected average weight reduction in clinical trials

• The importance of concurrent lifestyle intervention

• Common side effects: nausea, vomiting, diarrhoea, constipation

• Monitoring requirements: HbA1c, kidney function, blood pressure

• R ...